E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 11, 2011
April 20, 2020
dff4ff01-57a3-4145-a118-925a3a80b83c
Related Documents
S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Guidance DocumentMay 15, 2012Center for Drug Evaluation and Research
E2F Development Safety Update Report
Guidance DocumentAugust 23, 2011Center for Drug Evaluation and Research
Q8(R2) Pharmaceutical Development
Guidance DocumentNovember 20, 2009Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.